Table 2.
Variable | GnRHa (OPU + 6) | Control | P value |
---|---|---|---|
Patients, n | 165 | 163 | |
Basal FSH (IU/L) | 5.9 ± 1.7 | 5.8 ± 1.7 | 0.32 |
Basal LH (IU/L) | 5.1 ± 3.3 | 5.2 ± 3.1 | 0.67 |
Basal E2 (pg/mL) | 42.0 ± 20.9 | 58.8 ± 198.0 | 0.28 |
Basal Prolactin (ng/mL) | 21.5 ± 19.4 | 20.9 ± 12.7 | 0.74 |
LH (IU/L) day of triggering | 1.3 ± 1.0 | 1.2 ± 0.8 | 0.40 |
P (ng/mL) day of triggering | 1.1 ± 0.6 | 1.1 ± 0.6 | 0.92 |
E2 (pg/mL) day of triggering | 1,852.7 ± 889.7 | 2,034.8 ± 917.6 | 0.07 |
FSH OPU + 7 (IU/L)a | 0.9 ± 0.4 | 0.6 ± 0.3 | 0.001 |
LH OPU + 7 (IU/L)a | 4.1 ± 2.1 | 1.4 ± 1.4 | 0.001 |
E2 OPU + 7 (pg/mL)a | 1,274.3 ± 861.1 | 971.4 ± 849.6 | 0.001 |
P OPU + 7 (ng/mL)a | 53.3 ± 33.5 | 37.6 ± 23.0 | 0.001 |
β-hCG OPU +14 (mIU/mL) | 245.3 ± 377.0 | 191.7 ± 342.1 | 0.17 |
Values are mean ± SD, unless otherwise noted.
aStatistically significant difference between groups, with P < 0.05.
OPU, oocyte pick-up; FSH, follicle-stimulating hormone; LH, luteinizing hormone; P, progesterone; E2, estradiol; hCG, human chorionic gonadotropin.